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Nonporous silicone polymer coating of 
expanded polytetrafluoroethylene grafts 
reduces graft neointimal hyperplasia in dog 
and baboon models 
Alan B. Lumsden,  MB,  ChB,  Changy i  Chen,  MD,  Kelly A. Coyle, MD,  
John  C. Ofenloch,  MD,  Jenn-Hann Wang,  PhD,  H i ru tsugu  IC Yasuda, PhD,  and 
Stephen R. Hanson ,  PhD,  Atlanta, Ga., and Columbia, Mo. 
Purpose: Neointimal hyperplasia frequently develops after placement of  prosthetic vascular 
grafts and is a major cause of  graft failure. This study was an attempt to prevent vascular 
lesion formation by coating the graft luminal surface with a thin layer of  nonporous 
silicone polymer, and subsequently with an ultrathin layer of  vapor phase (plasma 
gas)--deposited fluoropolymer, thereby providing a smooth and chemically uniform 
surface that was postulated to limit pannus tissue ingrowth across the graft anastomoses. 
Methods: Bilateral femoral arteriovenous (AV) conduits were constructed in four dogs using 
expanded polytetrafluoroethylene graft materials (ePTFE; 6-mm inside diameter, 2.5-cm 
long). In each animal, one femoral AV shunt was constructed from a graft whose luminal 
surface was entirely coated with polymer. On the contralateral side, an uncoated graft 
served as a control. Bilateral aortoiliac grafts were placed in three baboons using 5-cm 
segments ofePTFE (4-mm inside diameter). One end (1 cm) of  each graft had been coated 
with polymer. In each animal, the coated end of  one graft was placed proximally and the 
coated end of the second graft was placed distally in the contralateral vessels. 
Results: All grafts were patent at 30 days. In the dog model, there was a significant 
reduction in graft neointimal area at the venous anastomoses for the coated grafts 
compared with the uncoated grafts (0.03 + 0.02 mm 2 and 1.11 + 0.54 mm 2, respectively; 
p < 0.05). In the baboon model, the silicone coating significantly reduced the graft 
neointimal thickness (0.003 + 0.003 mm vs 0.21 + 0.05 mm; p < 0.05) and neointimal 
area (0.05 + 0.08 mm 2 vs 0.82 + 0.58 mm2; p < 0.05). 
Conclusions: These data demonstrate that healing of  ePTFE grafts can be effectively 
modified by altering the physical properties of  the graft surface. Neointimal hyperplasia 
within ePTFE grafts is significantly reduced by the local application of  a fluorocarbon- 
coated, silicone-based polymer. The resulting raft flow surface ffectively prevents tissue 
ingrowth from the adjacent native vessel, thereby preserving the anastomosis luminal area. 
This approach could represent a new strategy for limiting graft surface anastomotic 
neointimal hyperplasia. (J Vasc Surg 1996;24:825-33.) 
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Recent advances in prosthetic materials have per- 
mitted the widespread application of synthetic grafts 
as arterial conduits and as arteriovenous (AV) fistulas. 
Expanded polytetrafluoroethylene (ePTFE) is the 
most commonly used material for hemodialysis access 
grafts and for reconstructing small and medium-sized 
arteries. In such vessels, however, patency may be 
significantly compromised by the development of 
anastomotic neointimal hyperplasia. Graft outcomes, 
including healing phenomena, inflammatory reac- 
tions, and hemocompatibility, will depend both on 
the surface chemical and on the physical properties of 
the graft material. Indeed, in previous animal studies 
in which the surface chemistries (but not texture) of 
ePTFE and Dacron grafts were selectively modified, a
significant reduction in early thrombogenicity was 
observed. 1-4 More recent studies with grafts treated 
using the same surface modification approaches, how- 
ever, have shown no differences (compared with 
control grafts) in later healing outcomes, including 
the extent ofpannus ingrowth and the development 
of anastomotic intimal esions, s 
These observations prompted the present study, 
which was undertal<en to evaluate the consequences 
for graft healing of the opposite strategy, that is, that 
of using grafts that were selectively modified with 
respect o surface texture and porosity, but under 
conditions of constant surface chemistry. It was an- 
ticipated that a graft surface that had been rendered 
relatively smooth and nontextured might better esist 
the attachment of thrombus and the ingrowth of 
vascular wall cells. The reduction of neointimal hy- 
perplasia by grafts that have surfaces unsuitable for 
tissue anchoring should therefore lead to an overall 
reduction in flow channel narrowing. Although late 
graft failure mechanisms were not specifically evalu- 
ated in the present series of studies, prevention of 
smooth muscle cell migration into the graft, and the 
subsequent production by these cells of connective 
tissue matrix, might ultimately be expected to pro- 
long graft patency, as well. 
Grafts were initially coated with a silicone-based 
polymer to achieve a flexible coating that did not 
noticeably affect he graft's mechanical properties. In 
addition, silicone polymers were considered to be 
suitable because they have been used in ma W appli- 
cations, including the modification of vascular grafts 
and other cardiovascular devices. 6-9 The coating pro- 
cedure was applied to standard ePTFE grafts and 
produced a smooth blood-contacting surface that was 
devoid of the usual ePTFE graft porosity and texture. 
Graft healing was then evaluated after implantation of 
these materials as femoral AV conduits in a dog model, 
and as aortoiliac interposition grafts in baboons. The 
polymer-coated and untreated control grafts were 
then compared quantitatively with respect o the 
development ofgraft and vessel anastomotic neointi- 
mal lesions. 
MATERIALS AND METHODS 
Preparation of grafts. The thin-walled ePTFE 
grafts (0.4-ram wall thickness, 30-t, tm internodal 
distance) used in the study were provided by W. L. 
Gore, Inc. (Flagstaff, Ariz.). For the studies in dogs, 
the graft (6-ram inside diameter, 2.5-cm long) was 
prepared by dip-coating the luminal surface of the 
entire graft in dimethylsiloxane polymer (Dow Corn- 
ing Corporation, Midland, Mich.), which cures on 
contact with air. For the baboon studies, the luminal 
surface of the graft (4-mm inside diameter, 5-cm 
long) was coated with silicone polymer at one end 
only, over a length of 1 cm, using the same coating 
procedure. The thickness of this silicone layer was just 
sufficient to obscure the pore structure of the under- 
lying graft (Fig. 1). 
To ensure a uniform and constant surface chemi- 
cal composition over the entire length of the grafts 
used in both the dog and baboon experiments, the 
luminal surfaces of all grafts (whether fully or par- 
tially coated with silicone polymer) were subse- 
quently coated with an ultrathin layer of gas 
phase-deposited polymer based on a monomer gas 
mixture of hexafluoroethane/hydrogen (HFE/H2). 
This method, which is known as plasma polymer- 
ization, refers to the formation and surface depo- 
sition of polymers under the influence of partially 
ionized gas (plasma). Because plasma polymerization 
often involves the use of an electrical glow discharge 
under vacuum, the term glow discharge polymeriza- 
tion has been used synonymously. The technique of 
plasma polymerization previously has been described 
in detail. ~° In our present studies, the surface plasma 
polymerization reactor that we used was specifically 
designed for coating the inner surface of tubing, as 
described, n This coating was applied by placing the 
graft in a high vacuum containing only HFE/H2, 
which was passed through the graft after gas ion- 
ization by a field of continuous electrical discharge. 
The reactive ions quickly reacted with and uniformly 
coated the exposed graft surface. Thus a glow dis- 
charge was created inside the graft tubing, and a thin 
coating was achieved by adjusting the pull rate 
through the plasma to maintain a thickness on the 
order of 30 nm. Using this method, the entire 
luminal surface of each graft was coated with an 
ultrathin layer of a plasma polymer derived from the 
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Fig. 1. Scanning electron microscope image of graft luminal surfaces. A,Untreated ePTFE graft 
(30 btm internodal distance) exhibits usual nodes and fibrils that characterize conventional ePTFE 
graft surface (original magnification, ×500). B, Scanning electron microscope image of treated 
ePTFE grafts shows that fibrillar-nodular structures were totally obscured by polymer coating 
(about 50 btm thick). 
HFE/H  2 monomer mixture. This produced a very 
thin, uniform, highly cross-linked plasma polymer 
layer superimposed onto the silicone polymer or 
ePTFE substrates. 2,11 Because the silicone polymer is 
also thin when compared with the thickness of the 
graft wall, it did not alter the handling characteristics 
of the graft, nor did the thin plasma polymer layer, 
which was highly flexible. 
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The luminal surfaces of segments of the silicone 
polymer-coated grafts were studied by scanning elec- 
tron microscopy to confirm that the fibrillar struc- 
tures and nodes of the ePTFE graft were obscured by 
the smooth, homogenous surface layer of silicone 
polymer, which was approximately 50gtm thick (Fig. 
1). The chemical composition of the plasma polymer 
surface layer was studied by electron spectroscopy for 
chemical analysis. The reflection spectra obtained 
using electron spectroscopy confirmed the chemical 
alteration of the luminal surfaces, including both the 
silicone-coated and uncoated ePTFE segments, by 
quantitation of relative numbers of surface carbon, 
hydrogen, and fluorine atoms. Plasma polymerization 
alone changed the surface chemistry but did not 
change the surface topography of standard ePTFE 
grafts. ~1 Because the graft surface chemical composi- 
tion was the same in all the baboon studies (HFE/H 2 
plasma polymer), which involved grafts only partially 
coated with the silicone polymer, any differences in
graft healing between the smooth and porous graft 
regions could be interpreted as being a result of the 
physical alteration i graft surface topography, that is, 
graft texture was the only independent variable in 
these studies. In the dog studies, by contrast, conven- 
tional ePTFE grafts were compared with grafts that 
had been fully coated with the smooth-walled silicone 
and plasma-based polymers. 
Animal models. All animal procedures were ap- 
proved by the Institutional Animal Care and Use 
Committee and were conducted in accordance with 
the federal guidelines (Guide For the Care and Use of 
Laboratory Animals, NIH Publication No. 86-23, 
revised 1985), and with the animal welfare act and 
applicable University policies. 
Four adult male mongrel dogs weighing 23 to 28 
kg were used in the study. Under general anesthesia 
and sterile conditions, the common femoral artery 
and vein were exposed bilaterally. On one side, ePTFE 
grafts (6-mm inside diameter, 4-cm long; full silicone 
coating) were implanted between the femoral artery 
and vein. On the contralateral side, an uncoated graft 
was placed as a control. End-to-side anastomoses 
were performed with running 6-0 polypropylene 
sutures. The incisions were closed with 3-0 polyga- 
lactin sutures. 
Three male baboons (Papio cynocephalus) that 
were 2 to 3 years of age and weighed 12 to 16 kg 
underwent implantation ofbilateral aortoiliac grafts. 
This model has been previously described.12-1s Briefly, 
after a midline incision, ePTFE grafts (4-mm inside 
diameter, 5-cm long; silicone polymer-coated at one 
end and plasma HFE/I-I 2 polymer-coated through- 
out) were placed bilaterally between the distal aorta 
and the common iliac artery using end-to-side anas- 
tomoses with continuous 7-0 polypropylene sutures. 
The distal aorta and common iliac artery were then 
ligated, with restoration of blood flow through the 
grafted segments. Because only one end of each of the 
ePTFE grafts was coated so as to be smooth-walled, 
the graft orientation in the individual animals was 
reversed between right- and left-side placements. 
Thus, in each animal, the coated end of one graft was 
placed as a proximal anastomosis and the coated end 
of the second graft was positioned as the distal 
anastomosis on the contralateral side. 
All animals were killed after 1 month by in vivo 
pressure-perfusion fixation. 13'16 The grafts, along 
with 3-cm segments of attached vessel at each anas- 
tomosis, were harvested and fixed in 10% buffered 
formalin (Baxter Diagnostics Inc., McGaw Park, Ill.). 
Histologic and morphometric analyses. After 
fixation, grafts were embedded in paraffin and sec- 
tioned at the midpoint between the heel and toe of 
each anastomosis, at a distance o f l  to 2 mm from the 
heel of each anastomosis, and at 5-ram intervals along 
the entire graft length. Five-micrometer s ctions were 
cut and stained with hematoxylin and eosin and with 
Vethoeff-Masson's stain. Cell ingrowth overlying the 
luminal surface of the graft adjacent to the anastomo- 
sis was considered to be graft neointima. Cell prolif- 
erative tissue overlying the internal elastic lamina of 
native vessels was considered to be vessel neointima. 
Morphometric measurements of the area of anasto- 
motic neointima were performed by computer image 
analysis oftware (Optimas, Bioscan, Inc., Edmonds, 
Wash.) on a magnified image relayed from a micro- 
scope-mountedvideo camera to a digitizing pad and 
video monitor (Thomas Optical, Columbus, Ga.) as 
previously described. 12,17 Graft neointimai thickness 
was calculated as the total area ofneointima divided by 
the length of underlying raft surface. Comparisons 
between groups were made with Student's t test 
(two-tailed) for paired data. Values are given as the 
mean + SEM. 
RESULTS 
Femoral AV ePTFE grafts. All of the femoral AV 
ePTFE grafts in dogs were patent at the time of 
harvest. Tissue ingrowth at the venous anastomoses 
was derived from the cut end of the adjacent native 
vessel. Total neointimal area within the graft at the 
venous anastomoses was significantly reduced for the 
smooth-walled polymer-coated grafts (0.03 + 0.02 
mm 2) compared with the uncoated control grafts 
(1.11 + 0.54 mm2;p < 0.05). More neointimal tissue 
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Fig. 2. Histologic sections of neointimal tissue from femoral AV grafts in canine model. A, 
Neointimal tissue was present in untreated graft at venous anastomosis. B, A small portion of 
neointimal tissue was present in silicone-treated graft at venous anastomosis. Verhoeff-Masson's 
stain (original magnification, xl00). 
was attached to the luminal surface of the untreated 
grafts (Fig. 2, A) than the silicone polymer-coated 
grafts (Fig. 2, B). The neoinlimal area within the 
adjacent vein was not significantly less when the 
anastomosis was constructed against polymer-coated 
grafts than against the untreated ePTFE grafts 
(0.10 +0.08 mm 2 and 0.14.+_0.09 mm 2, respec- 
lively; p > 0.5). 
Aortoil iac ePTFE grafts. All of the aortoiliac 
ePTFE grafts that were placed in baboons were 
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patent at 1 month. Neointima was present at all of 
the polymer-coated and untreated anastomoses. Six 
coated anastomoses and six uncoated anastomoses 
were compared with respect to graft neointimal 
thickness and area and with respect o native vessel 
neointimal thickness and area. With the uncoated 
anastomoses, maximal neointimal thickness was ap- 
parent immediately over the anastomosis and was 
gradually reduced in thickness on extension into the 
graft away from the anastomosis (Fig. 3, A). This 
neointima was firmly attached to the underlying 
uncoated ePTFE, as evidenced by a lack of separation 
during the harvesting and tissue processing. The 
healing pattern, however, was significantly altered by 
the presence of luminal polymer coating. There was 
minimal vascular cell ingrowth across the anastomosis 
of the coated graft (Fig. 3, B). In those areas where 
some growth had occurred, it was quite limited and 
appeared less well-attached tothe underlying smooth 
surface. A highly significant difference in the amount 
of neointima within the graft was apparent (Table I). 
Significant reductions in graft neointima at the 
smooth-walled anastomoses compared with the tex- 
tured anastomoses were seen with respect to measure- 
ments of both neointimal area (0.05 + 0.08 mm 2 and 
0.82 + 0.58 mm 2, respectively; p < 0.05) and neoin- 
timal thickness (0.003 + 0.003 mm 2 and 0.21 + 0.05 
mm 2, respectively; p < 0.05). Neointima formation 
was much less dramatically affected in the adjacent 
native artery as compared with that within the graft 
itself. There was no significant effect (p > 0.5) of the 
type of graft on the amount of the vessel neointima 
adjacent o either the smooth-walled or textured 
ePTFE grafts (Table I). Thus the silicone-plasma 
polymer graft coating significantly reduced graft 
neoinfimal hyperplasia; however, it did not affect he 
development of neoinfimal hyperplasia within the 
adjacent grafted vessels. 
DISCUSSION 
Dacron and ePTFE vascular prostheses have met 
with considerable clinical successes, yet are not ideal 
for reconstructing small and medium-sized arteries. 
At the present ime, more than 95% of grafts larger 
than 10 mm in diameter are made of knitted or woven 
Dacron of various fiber configurations and porosi- 
ties. ls-21 Teflon vascular grafts have been used for 
almost 40 years? 2,2a At present, 75% of the implanted 
grafts smaller than 10 mm in diameter are ePTFE?* 
Therefore, Dacron has been widely used for bypass 
procedures for larger arteries, whereas ePTFE is most 
commonly used for medium and small arteries. It is in 
the medium-sized and small vessels that neointimal 
hyperplasia n particular compromises long-term pa- 
tency. 
Both Dacron and ePTFE grafts are of porous or 
fabric construction because it is widely believed that 
these configurations permit flow surface healing as 
well as incorporation by external tissue. However, 
Dacron and ePTFE grafts may seldom heal com- 
pletely by true endothelialization. 2s27 Thus im- 
planted grafts may remain thrombogenic towards 
platelets for many years? s-3° ePTFE grafts, the focus 
of our present investigation, typically show neointima 
formation that is limited to anastomotic sites. ~3,2s,26 
Smooth muscle cells underlying endothelial cells are 
induced to migrate across the suture line, proliferate, 
and produce connective tissue matrix components 
under the influence of growth factors or other mito- 
gens. Such findings uggest that graft placement may 
produce chronic tissue injury and an ongoing inflam- 
matory response. 14,31 Interestingly, although ePTFE 
grafts of increased porosity (60 gm internodal dis- 
tance) may show rapid and uniform flow surface 
healing in animal models, is a limited clinical trial with 
a high-porosity ePTFE graft showed no benefit over 
standard porosity ePTFE. 31 Therefore, we chose to 
investigate the opposite strategy--that of reducing 
ePTFE graft porosity-based on the view that flow 
surface healing may not be necessary, and, in the case 
of small-diameter g afts, perhaps not even desirable. 
The coating of ePTFE with silicone rubber poly- 
mer, followed by a coating with a plasma polymer 
based on HFE/H2,  effectively abolished pannus 
tissue ingrowth and graft surface neointimal hyper- 
plasia in a baboon arterial graft interposition model 
and in a canine AV graft model. Adjacent vessel 
hyperplasia was not affected significantly in either 
study. Although limiting graft neointima develop- 
ment did not reduce the vascular surface neointima, it 
is conceivable that anastomotic neointima hyperpla- 
sia, which ultimately imits flow channel area and leads 
to thrombus formation, results in many cases from a 
lesion that may largely circumscribe the anastomosis. 
Thus, while eliminating only the graft surface neoin- 
tima would not prevent entirely stenotic tissue in- 
growth, it could delay the overall process ufficiently 
to extend the patency of certain grafts, such as dialysis 
access grafts. Our data, which indicate that the total 
neointimal area was in fact reduced (although all 
grafts were patent), are consistent with this hypoth- 
esis. Clearly, longer-term studies that assess patency 
rates will be required to confirm the benefit of this 
approach for delaying raft occlusion. 
Grafts were initially coated with a thin layer of 
silicone rubber polymer because this material is 
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Fig. 3. Histologic sections ofneointimal nastomotic ssue from aortoiliac ePTFE grafts placed 
in baboons. A, Significant neointimal tissue (N) was present in uncoated anastomosis, overlying 
ePTFE graft (G), and some neointima is present overlying media (M) of adjacent vessel. B, 
Minimal neointimal hyperplasia (N) is seen overlying polymer-coated graft surface (G), although 
a large neointima isseen luminal tovessel media (M) (original magnification, x30). 
tough, yet flexible, and did not detectably affect graft 
handling properties or suturability. Thus our ap- 
proach was simply to use as a substrate and to 
improve, if possible, a graft material that was accept- 
able clinically. There are several reasons why we then 
chose to coat hese grafts with a plasma polymer based 
on HFE/H  2. First, by coating both the silicone 
polymer-treated as well as the untreated ePTFE 
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Table I. Anastomotic neointimal hyperplasia 
of aortoiliac ePTFE grafts in baboons 
Uncoated Coated 
anastomoses anastomoses p 
Grafts 
Neointimal 0.21 + 0.05 0.003 + 0.003 <0.05 
thickness 
(ram) 
Neointimal area 0.82 + 0.58 0.05 + 0.08 <0.05 
(ram 2) 
Native vessels 
Neointimal 0.25 + 0.09 0.21 + 0.01 >0.5 
thickness 
(ram) 
Neointimal area 1.27 + 0.59 1.43 + 0.55 >0.5 
(mm 2) 
Bilateral aortoiliac grafts were placed in three baboons using 
5-cm-long ePTFE, one end (1 cm) of which had been coated with 
silicone polymer. The entire graft was then coated with plasma 
polymer based on HFE/H 2 (see Methods). All grafts were patent 
at 30 days. Six silicone polymer-coated anastomoses and six un- 
coated anastomoses were compared for neointimal thickness and 
area. The silicone/plasma polymer coating significantly reduced 
graft neointimal thickness and area; however, it did not affect 
neointimal hyperplasia within the adjacent native vessel. 
portions of each graft used in the baboon studies, we 
rendered uniform the entire graft surface chemistry, 
thereby eliminating variable surface composition as a 
confotmding variable for the interpretation f results. 
Second, the HFE/H 2 plasma polymer was chosen on 
the basis of our previous experience, which showed 
that this system produces a smooth, uniform, and 
reproducible ayer that is too thin (about 30 nm) to 
affect surface texture or morphologic features? Also, 
previous results in baboons Showed that this plasma 
polymer reduced significantly early platelet thrombus 
formation on treated grafts compared with conven- 
tional ePTFE grafts. 2Finally, silicone polymers may 
absorb lipids, calcium, and other blood constituents 
over long periods of time. The plasma polymer 
coating of the silicone polymer is advantageous be- 
cause it is deposited as a very tough, highly cross- 
linked, yet flexible barrier layer that not only prevents 
the absorption of plasma components but will also 
block the elution of low molecular species from the 
silicone polymer. Thus the approach of plasma poly- 
mer coating is well-designed to improve polymer 
durability and reduce possible toxicities. 
Two different animal models were used. The 
baboon arterial interposition model is appropriate for 
comparing rafts that have been modified at only one 
end because we and others have shown that in 
baboons uch interposition grafts heal by tissue in- 
growth and intimal thickening that is equivalent at 
proximal and distal anastomoses? 2-1~ This model 
largely eliminates anastomosis position (proximal or 
distal) as a potentially confounding variable for the 
interpretation of results. Dogs were also studied. 
Questions remain regarding the relevance of different 
animal models, and it was believed to be important to 
have confirming data in a second animal species. Such 
confirmation was provided by the finding that neoin- 
timal hyperplasia t the venous graft surface was 
virtually eliminated. In addition, we employed an AV 
graft model in the dog because the AV graft may be 
one clinical application that could benefit from im- 
proved graft performance, and because dogs have 
been studied extensively in this context. Finally, the 
dog study provided apositive comparison ofpolymer- 
treated ePTFE grafts with the untreated ePTFE graft 
material that is used clinically. Taken together, we 
believe that these data from two animal species 
support he conclusion that reducing raft texture 
and porosity may be a useful strategy for limiting graft 
anastomotic neointimal hyperplasia. 
We thank Deborah White, Johanna Anderson, Carolyn 
Suwyn, and Beverly Noe for expert echnical assistance. 
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